• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form D filed by Kindly MD Inc.

    6/26/25 6:01:43 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care
    Get the next $NAKA alert in real time by email
    SEC FORM D

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM D

    Notice of Exempt Offering of Securities

    OMB APPROVAL
    OMB Number: 3235-0076
    Estimated average burden
    hours per response: 4.00

    1. Issuer's Identity

    CIK (Filer ID Number) Previous Names
       None
    Entity Type
    0001946573
    Utah Therapeutic Health Center, PLLC
    Utah Therapeutic Health Center, LLC
    X Corporation
       Limited Partnership
       Limited Liability Company
       General Partnership
       Business Trust
       Other (Specify)

    Name of Issuer
    Kindly MD, Inc.
    Jurisdiction of Incorporation/Organization
    UTAH
    Year of Incorporation/Organization
    X Over Five Years Ago
       Within Last Five Years (Specify Year)
       Yet to Be Formed

    2. Principal Place of Business and Contact Information

    Name of Issuer
    Kindly MD, Inc.
    Street Address 1 Street Address 2
    5097 SOUTH 900 EAST, SUITE 100
    City State/Province/Country ZIP/PostalCode Phone Number of Issuer
    SALT LAKE CITY UTAH 84117 (385) 388-8220

    3. Related Persons

    Last Name First Name Middle Name
    Pickett Timothy
    Street Address 1 Street Address 2
    5097 South 900 East, Suite 100
    City State/Province/Country ZIP/PostalCode
    Salt Lake City UTAH 84117
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Barrera Jared
    Street Address 1 Street Address 2
    5097 South 900 East, Suite 100
    City State/Province/Country ZIP/PostalCode
    Salt Lake City UTAH 84117
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Cox Adam
    Street Address 1 Street Address 2
    5097 South 900 East, Suite 100
    City State/Province/Country ZIP/PostalCode
    Salt Lake City UTAH 84117
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Powell Amy
    Street Address 1 Street Address 2
    5097 South 900 East, Suite 100
    City State/Province/Country ZIP/PostalCode
    Salt Lake City UTAH 84117
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Robinson Christian
    Street Address 1 Street Address 2
    5097 South 900 East, Suite 100
    City State/Province/Country ZIP/PostalCode
    Salt Lake City UTAH 84117
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Seelhorst Gary
    Street Address 1 Street Address 2
    5097 South 900 East, Suite 100
    City State/Province/Country ZIP/PostalCode
    Salt Lake City UTAH 84117
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    4. Industry Group

       Agriculture
    Banking & Financial Services
       Commercial Banking
       Insurance
       Investing
       Investment Banking
       Pooled Investment Fund
    Is the issuer registered as
    an investment company under
    the Investment Company
    Act of 1940?
       Yes    No
       Other Banking & Financial Services
       Business Services
    Energy
       Coal Mining
       Electric Utilities
       Energy Conservation
       Environmental Services
       Oil & Gas
       Other Energy
    Health Care
       Biotechnology
       Health Insurance
    X Hospitals & Physicians
       Pharmaceuticals
       Other Health Care
       Manufacturing
    Real Estate
       Commercial
       Construction
       REITS & Finance
       Residential
       Other Real Estate
      
    Retailing
      
    Restaurants
    Technology
       Computers
       Telecommunications
       Other Technology
    Travel
       Airlines & Airports
       Lodging & Conventions
       Tourism & Travel Services
       Other Travel
      
    Other

    5. Issuer Size

    Revenue Range OR Aggregate Net Asset Value Range
       No Revenues    No Aggregate Net Asset Value
       $1 - $1,000,000    $1 - $5,000,000
       $1,000,001 - $5,000,000    $5,000,001 - $25,000,000
       $5,000,001 - $25,000,000    $25,000,001 - $50,000,000
       $25,000,001 - $100,000,000    $50,000,001 - $100,000,000
       Over $100,000,000    Over $100,000,000
    X Decline to Disclose    Decline to Disclose
       Not Applicable    Not Applicable

    6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

       Rule 504(b)(1) (not (i), (ii) or (iii))
       Rule 504 (b)(1)(i)
       Rule 504 (b)(1)(ii)
       Rule 504 (b)(1)(iii)
    X Rule 506(b)
       Rule 506(c)
       Securities Act Section 4(a)(5)
       Investment Company Act Section 3(c)
       Section 3(c)(1)    Section 3(c)(9)  
       Section 3(c)(2)    Section 3(c)(10)
       Section 3(c)(3)    Section 3(c)(11)
       Section 3(c)(4)    Section 3(c)(12)
       Section 3(c)(5)    Section 3(c)(13)
       Section 3(c)(6)    Section 3(c)(14)
       Section 3(c)(7)

    7. Type of Filing

    X New Notice Date of First Sale 2025-05-13    First Sale Yet to Occur
       Amendment

    8. Duration of Offering

    Does the Issuer intend this offering to last more than one year?
       Yes X No

    9. Type(s) of Securities Offered (select all that apply)

    X Equity    Pooled Investment Fund Interests
    X Debt    Tenant-in-Common Securities
    X Option, Warrant or Other Right to Acquire Another Security    Mineral Property Securities
       Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security    Other (describe)

    10. Business Combination Transaction

    Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
    X Yes    No

    Clarification of Response (if Necessary):

    11. Minimum Investment

    Minimum investment accepted from any outside investor $0 USD

    12. Sales Compensation

    Recipient
    Recipient CRD Number    None
    Cohen & Company Capital Markets 000144981
    (Associated) Broker or Dealer    None
    (Associated) Broker or Dealer CRD Number    None
    J.V.B. Financial Group, LLC 000104412
    Street Address 1 Street Address 2
    3 Columbus Circle, 24th FL
    City State/Province/Country ZIP/Postal Code
    New York NEW YORK 10019
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
    X Foreign/non-US
    CALIFORNIA
    CONNECTICUT
    FLORIDA
    ILLINOIS
    MICHIGAN
    NEW JERSEY
    NEW YORK
    TEXAS
    UTAH
    WYOMING

    Recipient
    Recipient CRD Number    None
    Anthem Securities LLC 000298454
    (Associated) Broker or Dealer    None
    (Associated) Broker or Dealer CRD Number    None
    10X Securities 000104410
    Street Address 1 Street Address 2
    One World Trade Center, FL85
    City State/Province/Country ZIP/Postal Code
    New York NEW YORK 10007
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
    X Foreign/non-US
    CALIFORNIA
    FLORIDA
    MINNESOTA
    NEBRASKA
    NEVADA
    NEW HAMPSHIRE
    TEXAS
    WASHINGTON

    13. Offering and Sales Amounts

    Total Offering Amount $711,694,558 USD
    or    Indefinite
    Total Amount Sold $711,694,558 USD
    Total Remaining to be Sold $0 USD
    or    Indefinite

    Clarification of Response (if Necessary):

    14. Investors

      
    Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
    Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
    156

    15. Sales Commissions & Finder's Fees Expenses

    Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

    Sales Commissions $20,636,596 USD
       Estimate
    Finders' Fees $293,400 USD
       Estimate

    Clarification of Response (if Necessary):

    Cohen & Company Capital Markets and Anthem Securities LLC are also entitled to equity fees in an amount equal to 2% and 0.5%, respectively, of the post-closing company's common stock.

    16. Use of Proceeds

    Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

    $0 USD
       Estimate

    Clarification of Response (if Necessary):

    Signature and Submission

    Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

    Terms of Submission

    In submitting this notice, each issuer named above is:
    • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
    • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
    • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

    Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

    For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

    Issuer Signature Name of Signer Title Date
    Kindly MD, Inc. /s/ Timothy Pickett Timothy Pickett Chief Executive Officer 2025-06-25

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

    * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


    Get the next $NAKA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAKA

    DatePrice TargetRatingAnalyst
    10/16/2025$2.00Buy
    B. Riley Securities
    9/3/2025$8.00Buy
    Maxim Group
    More analyst ratings

    $NAKA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Dalton John Merritt was granted 1,574,803 shares (SEC Form 4)

    4 - Kindly MD, Inc. (0001946573) (Issuer)

    12/18/25 8:14:39 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Chief Financial Officer Gendron Teresa S was granted 2,624,671 shares (SEC Form 4)

    4 - Kindly MD, Inc. (0001946573) (Issuer)

    12/18/25 8:13:20 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Gendron Teresa S

    3 - Kindly MD, Inc. (0001946573) (Issuer)

    12/9/25 7:36:04 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    SEC Filings

    View All

    SEC Form 424B3 filed by Nakamoto Inc.

    424B3 - Nakamoto Inc. (0001946573) (Filer)

    1/30/26 8:52:38 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Nakamoto Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Nakamoto Inc. (0001946573) (Filer)

    1/30/26 8:05:41 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    SEC Form 424B3 filed by Nakamoto Inc.

    424B3 - Nakamoto Inc. (0001946573) (Filer)

    1/23/26 4:05:26 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Kindly MD (dba Nakamoto) with a new price target

    B. Riley Securities initiated coverage of Kindly MD (dba Nakamoto) with a rating of Buy and set a new price target of $2.00

    10/16/25 8:26:43 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Maxim Group initiated coverage on Kindly MD (dba Nakamoto) with a new price target

    Maxim Group initiated coverage of Kindly MD (dba Nakamoto) with a rating of Buy and set a new price target of $8.00

    9/3/25 8:05:07 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KindlyMD Announces Authorization of Share Repurchase Program

    Program Enhances Financial Flexibility and Reflects Confidence in Long-Term Bitcoin Operations KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin company via its subsidiary Nakamoto Holdings, Inc. ("Nakamoto"), today announced that its Board of Directors (the "Board") has authorized a share repurchase program under which the Company may repurchase its outstanding common stock. "This share repurchase program reflects our confidence in the long-term value of the Company and adds an important degree of flexibility to our capital allocation framework," said David Bailey, Chairman and CEO of KindlyMD. "As shareholders ourselve

    12/18/25 8:00:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    KindlyMD Strengthens Leadership Team with Senior Finance Talent

    Former Jefferies Financial Group Executives Teri Gendron and John Dalton Join as Chief Financial Officer and Chief Accounting Officer & Controller, Respectively KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or the "Company"), a provider of integrated healthcare services and a Bitcoin treasury company via its subsidiary Nakamoto Holdings, Inc. ("Nakamoto"), today announced the appointments of Teri Gendron, former Chief Financial Officer of Markel Group Inc. and Jefferies Financial Group Inc., as Chief Financial Officer and Treasurer, and John Dalton, former Chief Financial Officer of Jefferies Finance LLC, as Chief Accounting Officer and Controller, effective immediately. Together, they bring de

    12/8/25 8:00:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    KindlyMD Reports Third Quarter 2025 Operational and Financial Results

    Completed Merger with Bitcoin Treasury Company Nakamoto Advanced Mission of Building Leading Bitcoin Ecosystem Through Accumulation of 5,398 Bitcoin in Treasury and Completion of Two Strategic Investments KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury company via its subsidiary Nakamoto Holdings, Inc. ("Nakamoto"), today announced its financial and operating results for the quarter ended September 30, 2025, along with an update on its Bitcoin treasury strategy. In May 2025, KindlyMD took a major strategic leap when it announced its merger with Nakamoto and subsequently raised approximately $540 million of

    11/19/25 4:30:00 PM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    $NAKA
    Leadership Updates

    Live Leadership Updates

    View All

    BTC Inc Appoints Brandon Green as Chief Executive Officer

    Reports Significant Year-to-Date Growth in Revenue and Global Audience Engagement BTC Inc (the "Company"), the leading provider of Bitcoin-related news and events, today announced the appointment of Brandon Green as Chief Executive Officer, effective immediately. In this role, Green will oversee the Company's strategic and operational direction, including leading the continued growth of Bitcoin Magazine and the global Bitcoin Conference series. As part of this leadership transition, David Bailey, Chairman and CEO of KindlyMD (NASDAQ:NAKA) and Co-Founder of BTC Inc, will step down as Chief Executive Officer of BTC Inc and continue to serve as the Company's Chairman of the Board, supporti

    11/17/25 11:01:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care

    Treasury Revolution Sparks 150% Stock Surges as Corporate Bitcoin Holdings Hit $113 Billion

    Equity Insider News Commentary Issued on behalf of CEA Industries, Inc. VANCOUVER, BC, Sept. 10, 2025 /PRNewswire/ -- Corporate treasury companies surge an average of 150% within 24 hours of announcing crypto adoption strategies, according to a 2025 Animoca Brands report[1], as digital asset treasuries amass $113 billion in Bitcoin stockpiles through September 2025[2]. The explosive momentum reflects a fundamental shift from traditional cash reserves to strategic cryptocurrency accumulation, with Crypto.com reporting over 90 public companies now holding Bitcoin on their balance sheets[3] as corporate America embraces digital assets as inflation hedges and growth catalysts. This treasury tran

    9/10/25 9:32:00 AM ET
    $BNC
    $CIFR
    $NAKA
    Industrial Machinery/Components
    Industrials
    Finance: Consumer Services
    Finance

    Nakamoto Holdings Appoints Andrew Creighton as Chief Commercial Officer to Lead Global Bitcoin Growth Strategy

    Nakamoto Holdings Inc. ("Nakamoto"), a Bitcoin-native holding company, which previously announced its anticipated merger with Kindly MD, Inc. (NASDAQ:NAKA) ("KindlyMD"), today announced the appointment of Andrew Creighton as Chief Commercial Officer. In this role, Andrew will lead Nakamoto's commercial strategy across global markets, including overseeing licensing, partnerships, capital formation, and regional expansion. Andrew is a seasoned operator with deep expertise in scaling international businesses, raising institutional capital, and securing transformational partnerships. He currently serves as Chief Commercial Officer of BTC Inc, publisher of Bitcoin Magazine and host of the annu

    6/25/25 9:00:00 AM ET
    $NAKA
    Medical/Nursing Services
    Health Care